摘要
0引言
中国为胃癌高发区,发病率高于欧美,死亡率在大城市居恶性肿瘤第二(男性)和第三位(女性)^[1]。根治性手术是胃癌唯一可获治愈的方法,但5年生存率(overall survival,OS)并不令人满意。2000年以前的胃癌术后5年OS:欧洲24.5%^[2],美国Ⅰ-Ⅱ期34%-70%,
出处
《癌症进展》
2012年第2期154-159,共6页
Oncology Progress
参考文献37
-
1National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology:Gastric Cancer (Chinese edition)[S].2010.27-27.
-
2Sant M,Allemani C,Santaquilani M. EUROCARE-4.Survival of cancer patients diagnosed in 1995-1999. Results and commentary[J].European Journal of Cancer,2009,(06):931-991.
-
3Hundahl SA,Phillips J L,Menck H R. The National Cancer Data Base Report on Poor Survival of U.S.gastric carcinoma patients treated with gastrectomy:Fifth Edition American Joint Committee on Cancer staging,proximal disease,and the "different disease" hypothesis[J].Cancer,2000,(04):921-932.
-
4Macdonald J S,Smalley S R,Benedetti J. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction[J].New England Journal of Medicine,2001,(10):725-730.doi:10.1056/NEJMoa010187.
-
5Maruyama K,Sasako M,Kinoshita T. Should systematic lymph node dissection be recommended for gastric cancer[J].European Journal of Cancer,1998,(10):1480-1489.
-
6Ng K,Meyerhardt JA,Fuchs CS. Adjuvant and neoadjuvant approaches in gastric cancer[J].Cancer,2007,(03):168-174.
-
7Gunderson LL. Gastric cancer-patterns of relapse after surgical resection[J].Seminars in Radiation Oncology,2002,(02):150-161.
-
8Wu C W,Hsiung C A,Lo S S. Nodal dissection for patients with gastric cancer:a randomised controlled trial[J].Lancet Oncology,2006,(04):309-315.
-
9Sasako M,Sano T,Yamamoto S. Randomized phase Ⅲ trial of standard D2 versus D2 + para-aortic lymph node (PAN) dissection (D) for clinically M0 advanced gastric cancer:JCOG9501[J].Journal of Clinical Oncology,2006,(18S):LBA4015.
-
10Macdonald JS. Role of post-operative chemoradiation in resected gastric cancer[J].Journal of Surgical Oncology,2005,(03):166-170.
同被引文献24
-
1Parkin DM, Pisani P, Ferlay J, et al. Global cancer statistics [ J ]. Ca Cancer J C lin, 1999,49 ( 1 ) : 33 - 64.
-
2Nation Comprehensive Cancer Network. Clinical practice guide lines in on- cology: Gastric Cancer(Chinese edition) [J]. 2010: 27.
-
3殷蔚伯,余子豪,徐国镇,等.放射肿瘤学[M].第4版.北京:中国协和医科大学出版社,2008:808.
-
4Henning GT, Schild SE, Stafford SL, et al. Results of irradiation or chemoirradiation following resection of gastric adenocarcinoma[J]. Int J Radiat Oncol Biol Phys,2000,46(3) : 589 - 598.
-
5Glimelius B. Role of adjuvant chemoradiotherapy for abdominal malingnan- eies[J]. Dig Surg,2003,20(3): 169 - 179.
-
6Powers BE, Gillette EL. Effects of irradiation on the supportive tissues of the gastrointestinal tract[M]//Potten CS, Hendry JH. Radiation and gut. New York: Elsevier Seienee, 1995:221 - 229.
-
7Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adonocarcinoma of the stomach or gastroesophageal junction [ J ]. N Engl J Med, 2001,345 (10) : 725 - 730.
-
8Kim S, Lim DH, Lee J, et al. An observational study suggesting clinical benefit fou adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarci- noma of the stomach [ J ]. Int J Radiat Oncol Biol Phys, 2005,63 (5) : 1 279 - 1 285.
-
9Hallissey MT, Dunn JA, Ward LC, et al. The second British stomach can-cer group trial of adjuvant radiothcrapy or chemotherapy in resectable gatfic cancer: five-years follow-up[J]. Lancet,1994,343(8 909): 1 309 - 1 312.
-
10Guzel Z, Szawlowski A, Jezioski K, et al. Postoperative radiotherapy for gastric cancer[J]. EurJ Cancer, 1999,35 (suppl 4): S154.
引证文献3
-
1张庆忠,刘月娟.序贯放化疗与单纯化疗治疗局部胃癌晚期的效果比较[J].中国医药指南,2014,12(30):211-212. 被引量:1
-
2张晕生,赵成会,王艳美,尚华,张学惠,李艳丽,张进,刘志伟.卡培他滨同步放化疗用于胃癌术后50例疗效分析[J].中国药业,2015,24(5):65-67. 被引量:5
-
3石校刚.以卡培他滨为基础同步放化疗方案用于胃癌根治术后患者的疗效观察[J].临床医药文献电子杂志,2016,3(17):3477-3477.
二级引证文献6
-
1卿三明.DOS方案治疗进展期胃癌患者围手术期40例[J].中国药业,2015,24(17):90-91. 被引量:2
-
2李巍,李海洲.华蟾素联合卡培他滨治疗老年胃癌患者的临床疗效分析[J].中国民康医学,2016,28(4):82-83. 被引量:1
-
3张秀凤,王宗宜,訾华浦,潘纪红,王海滨.卡培他滨单药节拍化治疗老年晚期胃癌的临床探讨[J].中外医疗,2016,35(7):7-9. 被引量:3
-
4何贵省,吴煌福,韩华.晚期胃癌与术后复发转移胃癌患者应用卡培他滨不同方案治疗的临床效果[J].临床和实验医学杂志,2016,15(8):774-777. 被引量:15
-
5石校刚.以卡培他滨为基础同步放化疗方案用于胃癌根治术后患者的疗效观察[J].临床医药文献电子杂志,2016,3(17):3477-3477.
-
6叶瑞智,文强,刘丽丹.中晚期胃癌术后序贯放化疗40例临床分析[J].中国基层医药,2017,24(16):2495-2498.
-
1吴密璐,李积德.胃癌高发区16例青年人胃癌临床分析[J].青海医药杂志,1997,27(9):16-17.
-
2郭虹,王聪珍,党世荣,季积德.胃癌高发区16例青年人胃癌临床分析[J].现代肿瘤医学,1996,4(4):232-233.
-
3詹文华.欧美结直肠癌诊治近况[J].中国实用外科杂志,1998,18(11):692-694. 被引量:5
-
4王玉涛,杨丽萍.鸦胆子油乳注射液联合奥沙利铂 5-氟尿嘧啶 亚叶酸钙方案治疗晚期胃癌的临床观察[J].实用医技杂志,2013,20(4):427-428. 被引量:2
-
5黄广建.在日本和欧美胃癌病人中的微卫星不稳定性[J].国外医学(外科学分册),2003,30(2):121-121.
-
6赵成会.怎样早期发现前列腺癌[J].医药与保健,2007,15(12):29-29.
-
7当前欧洲造血干细胞移植的趋势[J].中华医学信息导报,2002,17(20):14-14.
-
8邹立群,姜愚,黄媚娟,彭枫,罗锋,卢铀,魏于全.卡培他滨治疗转移性结直肠癌的初步疗效观察[J].癌症,2002,21(12):1376-1377. 被引量:1
-
9李玉升.直肠癌辅助治疗新进展[J].癌症进展,2009,7(4):407-412. 被引量:6
-
10袁媛,宫伟,徐荣天,王选杰,高华,董明,吴烨秋,王兰,王梅先,周宝森.胃癌高发区胃癌及其高危人群筛查[J].中华肿瘤杂志,1999,21(4):314-314. 被引量:12